Correlation Between ImmunoGen and Cardiff Oncology
Can any of the company-specific risk be diversified away by investing in both ImmunoGen and Cardiff Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ImmunoGen and Cardiff Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ImmunoGen and Cardiff Oncology, you can compare the effects of market volatilities on ImmunoGen and Cardiff Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ImmunoGen with a short position of Cardiff Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of ImmunoGen and Cardiff Oncology.
Diversification Opportunities for ImmunoGen and Cardiff Oncology
0.56 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between ImmunoGen and Cardiff is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding ImmunoGen and Cardiff Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardiff Oncology and ImmunoGen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ImmunoGen are associated (or correlated) with Cardiff Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardiff Oncology has no effect on the direction of ImmunoGen i.e., ImmunoGen and Cardiff Oncology go up and down completely randomly.
Pair Corralation between ImmunoGen and Cardiff Oncology
If you would invest 211.00 in Cardiff Oncology on September 6, 2024 and sell it today you would earn a total of 30.00 from holding Cardiff Oncology or generate 14.22% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 1.56% |
Values | Daily Returns |
ImmunoGen vs. Cardiff Oncology
Performance |
Timeline |
ImmunoGen |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Cardiff Oncology |
ImmunoGen and Cardiff Oncology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ImmunoGen and Cardiff Oncology
The main advantage of trading using opposite ImmunoGen and Cardiff Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ImmunoGen position performs unexpectedly, Cardiff Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiff Oncology will offset losses from the drop in Cardiff Oncology's long position.ImmunoGen vs. Madrigal Pharmaceuticals | ImmunoGen vs. TG Therapeutics | ImmunoGen vs. Terns Pharmaceuticals | ImmunoGen vs. Hepion Pharmaceuticals |
Cardiff Oncology vs. Reviva Pharmaceuticals Holdings | Cardiff Oncology vs. PDS Biotechnology Corp | Cardiff Oncology vs. Reviva Pharmaceuticals Holdings | Cardiff Oncology vs. Eyenovia |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |